🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, single-center, Phase II trial designed to estimate i...
Status
Unknown
Location
Istituto Clinico Humanitas
Start Date
2020-01-30
Trial ID
NCT04435977
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of Cabozan...
Status
Completed
Location
Istituto Oncologico Veneto
Start Date
2019-02-27
Trial ID
NCT04416646
Treatments Being Tested
This study will compare the efficacy and safety of belzutifan + lenvatinib ...
Status
Active Not Recruiting
Location
Ironwood Cancer & Research Centers ( Site 0077)
Start Date
2021-02-25
Trial ID
NCT04586231
Treatments Being Tested
The study is a multi-center, multi-national, open label, single arm Phase I...
Status
Completed
Location
U.Z. Leuven - Campus Gasthuisberg (147)
Start Date
2017-02-02
Trial ID
NCT02216578
Treatments Being Tested
This is a multi-site, three-cohort phase II trial of cabozantinib for IMDC ...
Status
Recruiting
Location
Fox Chase Cancer Center
Start Date
2022-01-21
Trial ID
NCT05263050
Treatments Being Tested
Tthe primary objective of this study is to compare blinded Independent Radi...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2018-04-24
Trial ID
NCT03428217
Treatments Being Tested
Hepatocellular carcinoma (HCC) is a common tumor (the 8th leading cause of ...
Status
Completed
Location
CHU Amiens Picardie - Hôpital Sud
Start Date
2019-09-09
Trial ID
NCT03963206
Treatments Being Tested
Patients suffering from advanced stage hepatocellular carcinoma (HCC) who h...
Status
Completed
Location
Helios Klinikum Bad Saarow
Start Date
2020-12-08
Trial ID
NCT04511455
Treatments Being Tested
This is an open-label, non-randomized, phase 2 study to assess the feasibil...
Status
Terminated
Location
Brigham and Women's Hospital
Start Date
2014-02
Trial ID
NCT02036476
Treatments Being Tested
This is an open-label phase II clinical trial designed to allow a prelimina...
Status
Terminated
Location
University of Pittsburgh Cancer Institute- Hillman Cancer Center
Start Date
2015-12
Trial ID
NCT02132598
Treatments Being Tested